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The assembly and budding of human immunodeficiency virus type 1, encoded solely in the Gag protein precursor Pr55Gag,
occur at the plasma membrane of infected cells. However, little is known about the routing of the Gag molecule from its site
of synthesis in the cytoplasm to the site of budding, with past studies suggesting that the cytoskeleton, particularly actin, may
be involved in the translocation. We have constructed a T7 promoter-driven gag gene fusion with green fluorescent protein
(GFP) that expresses Gag-GFP in both cells and supernatant. The distribution of Gag-GFP was the same as Gag only,
suggesting that cellular routing was not affected by fusion to GFP, and using colabelling techniques, Gag-GFP was shown to
have no particular colocalisation with actin. After detergent extraction of expressing cells, Gag and Gag-GFP remained cell
associated, whereas GFP only was wholly released. These data suggest that Gag may associate with other cytoskeletal
components or, perhaps more likely, that a partial assembly to a large-molecular-weight intermediate occurs before
localisation at the plasma membrane. © 1999 Academic Press
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aINTRODUCTION
Retroviruses were originally classified on the basis of
heir morphogenesis with a clear distinction between
hose members of the family that assemble at the plasma
embrane and those that assemble cytoplasmically
Nermut and Hockley, 1996). Lentiviruses, such as hu-
an immunodeficiency virus (HIV), exhibit a C-type mor-
hology in which assembly and budding co-occur at the
lasma membrane. Both the assembly and budding sig-
als are encoded within the Gag Pr55 precursor protein,
he only protein required for virus assembly, and plasma
embrane localisation requires myristoylation of Gag at
he amino-terminus (Jones and Morikawa, 1998). The
lassic morphological distinction between retroviruses
hat assemble before or during budding has been mod-
rated in recent years by the finding that mutations in
ag can alter the site of assembly. For example, the type
retrovirus Mason–Pfizer monkey virus (MPMV) nor-
ally assembles before plasma membrane localisation
et can be switched to plasma membrane assembly by a
utation in the matrix domain of MPMV Gag (Rhee and
unter, 1991). Similarly, although HIV normally assem-
les at the plasma membrane, mutation or deletion of the
atrix region (Freed et al., 1994; Lee and Linial, 1994) or
revention of myristoylation (Gheysen et al., 1989)
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20auses intracellular assembly. Thus the ability to assem-
le is not necessarily linked to the site of assembly.
Distinct sites of assembly demand mechanisms for
rotein localisation to those sites, and for retroviruses
ith C-type morphology, the involvement of the cytoskel-
ton has long been invoked to explain the migration of
r55Gag from the cytoplasm to the plasma membrane
reviewed in Krausslich and Welker, 1996). Purified HIV
reparations have been reported to contain actin (Arthur
t al., 1992), and the release of HIV-1 from the infected
ells is reduced by treatment with the actin inhibitor
ytochalasin D (Rey et al., 1996; Sasaki et al., 1995).
irect evidence has also been provided for an interac-
ion of actin and Pr55Gag (Rey et al., 1996). However, in
hese studies, it is difficult to distinguish between phys-
cal entrapment of the Gag precursor by cytoskeletal
omponents and a specific interaction. To reassess any
ossible Gag–actin interaction, we have constructed a
usion between Gag and green fluorescent protein (GFP)
hat can be detected directly in cells by fluorescent
icroscopy. Using this fusion protein, we examined the
olocalisation of Gag and actin in situ.
RESULTS AND DISCUSSION
onstruction of Gag-GFP fusion protein
A gene fusion between the coding regions of Gag and
FP was achieved by ligation of DNA fragments gener-
ted from each gene through PCR. The gfp gene (Cra-
eri et al., 1996) was amplified by using the forward
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21TAGGING THE HIV GAG PROTEINrimer 59-CCGGGAATTCATGGCTAGCAAAGGAGAAGAA-
TTTTCAC-39 and the reverse primer 59-GGCCATC-
ATTTTGTAGAGCTCATCCATGCCATGTG-39 to generate
716-bp fragment flanked by unique restriction site
coRI at the 59 end and ClaI at 39 end. The PCR product
as cloned directly into pGEM-T (Promega) downstream
f the T7 RNA polymerase promoter to produce plasmid
GEM-GFP. The HIV-1 BH10gag gene was amplified us-
ng the forward primer 59-CCGGGAATTCATGGGTGC-
AGAGCGTCAGTATTAAG-39 and the reverse primer 59-
CGGGAATTCATTAGCCTGTCTCTCAGTACAATCTTTC-39
o generate a 1416-bp fragment flanked by unique EcoRI
estriction sites (underlined) and cloned directly into the
coRI site present in pGEM-GFP to produce pGEM-Gag-
FP. The gag fragment amplified encoded a Gag protein
p46) that deleted the p1 and p6 domains because this
as been shown previously to express a more stable
orm of Gag and to retain all assembly information
Jowett et al., 1992; Zhang et al., 1996). A plasmid ex-
ressing Gag only under control of the T7 promoter was
imilarly constructed (Fig. 1). Plasmids carrying inserts
enerated by PCR were sequenced before use.
ag-GFP fusion protein is efficiently expressed in
uman cells
To determine whether expression of the Gag-GFP fu-
ion protein was comparable to that of Gag only, the
xpression of Gag and Gag-GFP from the T7 promoter
lasmids was compared in HeLa cells after infection
ith vaccinia virus expressing T7 polymerase (vvT7–3 at
–10 PFUs/cell) (Fuerst et al., 1986; Perrin et al., 1998). At
2 h posttransfection, the cells and supernatant were
arvested and the presence of each antigen was deter-
ined by Western blot using Gag-specific monoclonal
ntibodies. Efficient expression of immunoreactive
ands of the expected molecular weights was observed
or each protein in both cell and supernatant fractions,
FIG. 1. Schematic representation of the Gag-GFP constructs used in
he recognition sites for the restriction enzymes EcoRI and ClaI used
recursor is indicated. The Gag constructs encode the wild-type aminlthough the level of Gag-GFP in the supernatant was ieduced compared with Gag only (Fig. 2). Both antigens
anded at 45% sucrose in velocity gradient analysis of
he supernatant antigen, suggesting particle formation
imilar to that described for the Gag-V3 loop chimeric
articles of HIV-2 (Luo et al., 1992). Expression of GFP
nly lead to antigen in only the cellular fraction (not
hown).
To examine the distribution of Gag-GFP in HeLa cells
fter transfection, cells on coverslips were transfected
ith pGEM-GFP, pGEM-Gag, and pGEM-Gag-GFP as
escribed except for the inclusion of 10 mM hydroxyurea
n the media to minimise the cytopathic effects of vac-
inia virus infection (Vos and Stunnenberg, 1988). Direct
luorescence was observed by confocal microscopy (Du-
artre et al., 1996) at 15 h posttransfection for the GFP and
ag-GFP constructs and indirectly for Gag only after
ork. The position of the T7 RNA polymerase promoter (T7prm) and of
cloning strategy are indicated. Each of the subdomains of the Gag
nus and so are myristoylated after expression in HeLa cells.
FIG. 2. Expression of Gag and Gag-GFP in HeLa cells after infection
ith vaccinia virus TF7–3 and transfection with plasmids described in
ig. 1. Cell lysates and supernatants were analysed by 10% SDS–PAGE
nd Western blotting using a mixture of Gag monoclonal antibodies
RP308 and ARP315 (Holmes, 1991). The positions of Gag and Gag-
FP are indicated on the right, and those of molecular weight (MW)
arkers are indicated on the left. The control lane, V, contained cellsthis w
in thenfected with vvTF7–3 alone.
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22 PERRIN-TRICAUD, DAVOUST, AND JONESixation and immunostaining. GFP fluorescence was
een throughout the cytoplasm and the nucleus of cells
s previously reported (Ogawa et al., 1995), whereas
ag-GFP fluorescence was restricted to the cytoplasm
Figs. 3a and 3b). Indirect immunofluorescence staining
f Gag after transfection of pGEM-Gag showed the same
istribution as Gag-GFP (Fig. 3c). No fluorescence was
bserved with mock-transfected cells (not shown). From
hese data, we conclude that the expression and distri-
ution of Gag-GFP are unaltered compared with that of
ag alone and that Gag-GFP represents a meaningful
eporter for the localisation of Gag within the expressing
ell.
ellular location of Gag-GFP and actin
Cellular fractionation experiments on HIV-1-infected
EM cells or COS-7 cells expressing pr55Gag have
hown a variable level of Gag antigen associated with
he detergent-insoluble fraction (Rey et al., 1996). Indirect
mmunofluorescence, however, provided only weak di-
ect evidence for colocalisation of actin and Gag, possi-
ly due to the sample processing involved. To reexamine
his association with less harsh procedures, HeLa cells
ere transfected with pGEM-GFP or pGEM-Gag-GFP as
bove, and the locations of Gag-GFP and GFP were
ssessed at 15 h posttransfection using GFP intrinsic
luorescence. Actin was visualised in the same cells
sing phalloidin conjugated to Texas red. Gag expres-
ion was distributed throughout the cell with no particu-
ar subcellular location, and there was no apparent as-
ociation with the actin filaments, which were clearly
FIG. 4. Confocal colocalisation analysis of Gag-GFP and actin filame
onfocal visualisation of actin and GFP as described. Gag location is
ouble labelling is shown in the right column (GFP-Gag in green and a
FIG. 3. Distributions of GFP, Gag-GFP, and Gag in HeLa cells. HeL
GEM-Gag (c) and fixed 15 h posttransfection with 4% paraformaldehyd
ntibody followed by an anti-mouse secondary antibody conjugated toising sections through the same cell are shown from top to bottom.isible (Fig. 4, middle column). A series of sections rising
hrough the expressing cell showed that lack of interac-
ion was not associated with any one plane of view (Fig.
, top to bottom), although a few colabeled filaments
ere seen at the apex of the cell, probably due to the
onstriction enforced on each antigen when present in
uch a small area (Fig. 4). Similar results were obtained
ith GFP-expressing cells (not shown), suggesting no
referential association between actin and Gag.
ffects of detergent extraction on the Gag protein
A lack of association between Gag and actin in situ
ould indicate a failure of Gag-GFP to adopt a meaning-
ul protein conformation capable of Gag assembly de-
pite the apparent Gag-specific cellular distribution of
ntigen (c.f., Figs. 2 and 3). To ensure that this was not
he case, we assessed Gag-expressing cells for the
bility to release fluorescence after detergent extraction.
ack of detergent-induced antigen release is a hallmark
f the assembly competent precursor Gag antigen but
ot of Gag fragments that do not assemble (Rey et al.,
996). HeLa cells were transfected as for Fig. 4 and
nalysed at 15 h posttransfection, but in these experi-
ents, cells were incubated for 4 min at room tempera-
ure in extraction buffer (1 mM CaCl2, 1 mM MgCl2, 150
M NaCl, 20 mM HEPES, 300 mM sucrose, 0.5% Triton
-100, 1 mM PMSF) before confocal microscopy. Under
hese conditions, HeLa cells remained adhered to the
lass coverslips and maintained excellent substructure.
FP was completely extracted by this procedure, yet
La cells were transfected with pGEM-Gag-GFP and processed for the
in the left column, and actin location is shown in the center column.
red). A colocalisation, if it occurs, causes a bright yellow colour. Four
were transfected with either pGEM-GFP (a), pGEM-Gag-GFP (b), or
ag staining, slides were processed with a mix of anti-Gag monoclonal
red.nts. He
shown
ctin ina cells
e. For G
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24 PERRIN-TRICAUD, DAVOUST, AND JONESag and Gag-GFP remained associated with the cell
Fig. 5).
Much of the evidence concerning the role of actin in
IV-1 morphogenesis is circumstantial and has relied on
ofractionation of variable quantities of cytoskeletal and
ag proteins (Krausslich and Welker, 1996). Even where
urified components have been used to assess an inter-
ction, the stoichiometry of Gag binding to actin has
een variable (Rey et al., 1996). This argues against a
equence-specific interaction but in favour of an indirect
inding dependent on a property of Gag that itself varies.
he pathway of HIV-1 Gag assembly from the ribosome
o the complete particle is poorly understood but is
hought to consist of two broad stages: aggregation of
ag antigen at the plasma membrane, followed by or-
ered oligomerisation to form the virion shell. However,
he in vitro assembly of Gag antigens indicates that there
s no formal need to associate with the plasma mem-
rane to assemble (Gross et al., 1997) and that limited
ssembly may occur before membrane localisation. In-
eed, when mixtures of plasma membrane targeted and
ontargeted HIV-1 Gag molecules are produced, by co-
xpression or by treatment with an antimyristoylation
rug, both molecules are found in the released particle
Morikawa et al., 1996; Smith et al., 1993; Wang et al.,
994), suggesting limited assembly occurs before mem-
rane localisation. Direct observation of multimeric
orms of Gag in solution has also been reported recently
Morikawa et al., 1998).
In this work, we confirmed that Gag as a Gag-GFP
usion protein is present in a detergent-nonextractable
orm after expression in HeLa cells, but we were unable
o show a convincing association with actin in situ de-
pite direct observation using confocal microscopy
hrough many planes of the expressing cell. We suggest
hat this apparent discrepancy may be explained by
artial Gag assembly to large-molecular-weight oli-
omers as part of the normal assembly pathway before
FIG. 5. Distribution of Gag, Gag-GFP, and GFP only in HeLa c
GEM-Gag-GFP (a), pGEM-Gag (b), or pGEM-GFP (c) and visualised aembrane localisation. Such oligomers may becomehysically entrapped by actin microfilaments after in vivo
xtraction, giving rise to the various reports of an inter-
ction. The characterisation of such intermediates may
elp to identify the individual stages of the assembly
rocess.
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